Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Current and future status of JAK inhibitors
DP McLornan, JE Pope, J Gotlib, CN Harrison - The lancet, 2021 - thelancet.com
An enhanced understanding of the importance of Janus kinase (JAK) and signal transducer
and activator of transcription (STAT) signalling in multiple disease states has led to an …
and activator of transcription (STAT) signalling in multiple disease states has led to an …
Mechanisms and consequences of Jak–STAT signaling in the immune system
Abstract Kinases of the Jak ('Janus kinase') family and transcription factors (TFs) of the STAT
('signal transducer and activator of transcription') family constitute a rapid membrane-to …
('signal transducer and activator of transcription') family constitute a rapid membrane-to …
Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation
Cytokines signal through cell surface receptor dimers to initiate activation of intracellular
Janus kinases (JAKs). We report the 3.6-angstrom–resolution cryo–electron microscopy …
Janus kinases (JAKs). We report the 3.6-angstrom–resolution cryo–electron microscopy …
Targeted protein degradation by PROTACs
TK Neklesa, JD Winkler, CM Crews - Pharmacology & therapeutics, 2017 - Elsevier
Targeted protein degradation using the PROTAC technology is emerging as a novel
therapeutic method to address diseases driven by the aberrant expression of a disease …
therapeutic method to address diseases driven by the aberrant expression of a disease …
Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance
Glioblastoma, the most common and aggressive malignant brain tumor, is propagated by
stem-like cancer cells refractory to existing therapies. Understanding the molecular …
stem-like cancer cells refractory to existing therapies. Understanding the molecular …
[HTML][HTML] Dual targeting of oncogenic activation and inflammatory signaling increases therapeutic efficacy in myeloproliferative neoplasms
Genetic and functional studies underscore the central role of JAK/STAT signaling in
myeloproliferative neoplasms (MPNs). However, the mechanisms that mediate …
myeloproliferative neoplasms (MPNs). However, the mechanisms that mediate …
JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition
Since its discovery, the Janus kinase-signal transduction and activation of transcription (JAK-
STAT) pathway has become recognized as a central mediator of widespread and varied …
STAT) pathway has become recognized as a central mediator of widespread and varied …
The molecular regulation of Janus kinase (JAK) activation
The JAK (Janus kinase) family members serve essential roles as the intracellular signalling
effectors of cytokine receptors. This family, comprising JAK1, JAK2, JAK3 and TYK2 (tyrosine …
effectors of cytokine receptors. This family, comprising JAK1, JAK2, JAK3 and TYK2 (tyrosine …
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
D Hong, R Kurzrock, Y Kim, R Woessner… - Science translational …, 2015 - science.org
Next-generation sequencing technologies have greatly expanded our understanding of
cancer genetics. Antisense technology is an attractive platform with the potential to translate …
cancer genetics. Antisense technology is an attractive platform with the potential to translate …
A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
Abstract N 6-methyladenosine (m6A) on mRNAs is critical for various biological processes,
yet whether m6A regulates drug resistance remains unknown. Here we show that …
yet whether m6A regulates drug resistance remains unknown. Here we show that …